XAF1
XIAP-associated factor 1
Also known as: BIRC4BP, HSXIAPAF1, XAF1_HUMAN, XIAPAF1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6GPH4
- Gene
- XAF1
- Ensembl
- ENSG00000132530
- Chromosome
- 17
- Canonical length
- 301 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
This gene encodes a protein which binds to and counteracts the inhibitory effect of a member of the IAP (inhibitor of apoptosis) protein family. IAP proteins bind to and inhibit caspases which are activated during apoptosis. The proportion of IAPs and proteins which interfere with their activity, such as the encoded protein, affect the progress of the apoptosis signaling pathway. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
Canonical amino-acid sequenceUniProt
301 residues, UniProt reviewed canonical sequence.
>Q6GPH4|XAF1
1 MEGDFSVCRN CKRHVVSANF TLHEAYCLRF LVLCPECEEP VPKETMEEHC KLEHQQVGCT
61 MCQQSMQKSS LEFHKANECQ ERPVECKFCK LDMQLSKLEL HESYCGSRTE LCQGCGQFIM
121 HRMLAQHRDV CRSEQAQLGK GERISAPERE IYCHYCNQMI PENKYFHHMG KCCPDSEFKK
181 HFPVGNPEIL PSSLPSQAAE NQTSTMEKDV RPKTRSINRF PLHSESSSKK APRSKNKTLD
241 PLLMSEPKPR TSSPRGDKAA YDILRRCSQC GILLPLPILN QHQEKCRWLA SSKGKQVRNF
301 SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against XAF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 69 nTPM
Expression across tissuesHPA
Tissue
- liver: 69 nTPM
- spleen: 67 nTPM
- ovary: 59 nTPM
- salivary gland: 45 nTPM
- heart muscle: 39 nTPM
- lung: 38 nTPM
Single-cell type
- vascular endothelial cells: 154 nCPM
- ovarian stromal cells: 128 nCPM
- microglia: 125 nCPM
- leydig cells: 87 nCPM
- endometrial stromal cells: 76 nCPM
- pituitary stem cells: 75 nCPM
Immune cell
- basophil: 17 nTPM
- intermediate monocyte: 13 nTPM
- non-classical monocyte: 13 nTPM
- neutrophil: 11 nTPM
- T-reg: 9.9 nTPM
- classical monocyte: 9.6 nTPM
Brain region
- medulla oblongata: 61 nTPM
- spinal cord: 49 nTPM
- thalamus: 48 nTPM
- pons: 47 nTPM
- cerebral cortex: 46 nTPM
- basal ganglia: 43 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.11
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, TRAF-type
- Zinc finger, RING/FYVE/PHD-type
- TRAFD1/XAF1, zinc finger
- Innate Immunity and Apoptosis Regulator
- TRAFD1/XAF1, zinc finger
- XIAP-associated factor 1, C-terminal superfamily
- XIAP-associated factor 1, C-terminal
- XIAP-associated factor 1 C-terminal domain
- XIAP-associated factor 1-like, N-terminal zinc finger
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of XAF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads XAF1 as an antibody target. Whether an autoantibody or antibody against XAF1 could matter depends on whether native XAF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
XAF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label XAF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...